Skip to main content

Table 1 Description of the characteristics of the surgical procedures according to the site and the period

From: Staphylococcus aureus screening and preoperative decolonisation with Mupirocin and Chlorhexidine to reduce the risk of surgical site infections in orthopaedic surgery: a pre-post study

Variables

Total

North Site

South Site

n= 5348

North Total

n= 1117

01.01.2014 – 31.01.2017

n= 543

01.02.2017 – 30.06.2020

n= 574

P value

South Total

n= 4231

01.01.2014 – 31.01.2017

n= 1926

01.02.2017 – 30.06.2020

n= 2305

P value

Age in years, median (Q1-Q3)

68 (60 – 76)

64 (51 – 74)

64 (51 – 74)

64 (50 – 75)

0.561

68 (61 – 76)

69 (61 – 76)

69 (61 – 76)

0.441

Male gender, n(%)

2364 (44.2)

573 (51.3)

276 (50.8)

297 (51.7)

0.760

1791 (42.3)

830 (43.1)

961 (41.7)

0.358

CCI ,median (Q1-Q3)

0 (0 – 1)

0 (0 – 1)

0 (0 – 1)

0 (0 – 1)

0.595

0 (0 – 1)

0 (0 – 1)

0 (0 – 1)

0.014

BMI in kg/m2

median (Q1-Q3)

27.7 (23.3 – 32.47)

27.2 (22.9 – 32.0)

29.2 (24.9 – 32.6)

27 (22.8 – 31.9)

0.162

27.7 (23.4 – 32.7)

28.0 (23.4 – 32.5)

27.7 (23.4 – 32.7)

0.832

Altemeier classification, n(%)

1

5308 (99.3)

1081 (96.8)

524 (96.5)

557 (97.0)

0.611

4227 (99.9)

1924 (99.9)

2303 (99.9)

0.857

2

40 (0.7)

36 (3.2)

19 (3.5)

17 (3.0)

 

4 (0.1)

2 (0.1)

2 (0.1)

 

ASA score, n (%)

 

n=4640

n= 909

n= 371

n= 539

0.398

n=3730

n= 1622

n= 2108

< 0.001

1

896 (19.3)

197 (21.7)

73 (20.6)

124 (22.3)

 

699 (18.7)

340 (21.8)

359 (16.5)

 

2

2699 (58.2)

451 (49.6)

188 (53.1)

264 (47.4)

2248 (60.3)

921 (59.0)

1327 (61.2)

 

3

1020 (22.0)

246 (27.1)

88 (24.9)

158 (28.5)

774 (20.8)

295 (18.9)

479 (22.1)

4

24 (0.5)

15 (1.6)

5 (1.4)

10 (1.8)

9 (0.2)

4 (0.3)

5 (0.2)

Time between admission and the surgery in hours, median (Q1-Q3)

17 (16 – 19)

19 (17-22)

19 (17 - 21)

20 (18 – 23)

< 0.001

17 (16 – 19)

17 (16 – 19)

17 (16 – 19)

0.218

Duration of surgery in minutes, median (Q1-Q3)

68 (52 – 89)

82 (62 – 114)

77.5 (57 - 109)

87 (66 – 120)

< 0.001

66 (50 – 83)

64 (47 – 83)

67 (53 - 82)

< 0.001

Type of surgery,

n (%)

OS of the UEF

20 (0.4)

11 (0.98)

3 (0.6)

8 (1.4)

0.089

9 (0.2)

7 (0.4)

2 (0.1)

0.090

Other OS

393 (7.3)

292 (26.1)

149 (27.4)

143 (24.9)

101 (2.4)

40 (2.1)

61 (2.7)

Knee prostheses

2458 (46.0)

234 (20.9)

127 (23.4)

107 (18.6)

2224 (52.6)

998 (51.8)

1226 (53.2)

Hip prostheses

1938 (36.2)

392 (35.1)

185 (34.1)

207 (36.1)

1546 (36.5)

733 (36.1)

813 (35.3)

Revision of knee prosthesis

190 (3.6)

37 (3.3)

17 (3.1)

20 (3.5)

153 (3.6)

63 (3.3)

90 (3.9)

Revision of hip prosthesis

349 (6.5)

151 (13.5)

62 (11.4)

89 (15.5)

198 (4.7)

85 (4.4)

113 (4.9)

S. aureus SSI, n (%)

30 (0.6)

14 (1.3)

10 (1.8)

4 (0.7)

0.086

16 (0.4)

9 (0.5)

7 (0.3)

0.388

CCFM SSI, n (%)

43 (0.8)

21 (1.9)

13 (2.4)

8 (1.4)

0.219

22 (0.5)

12 (0.6)

10 (0.4)

0.394

All SSI, n (%)

100 (1.9)

54 (4.8)

24 (4.4)

30 (5.2)

0.619

46 (1.1)

18 (0.9)

28 (1.2)

0.381

  1. Legend: The p-values correspond to the comparisons of the periods before (01/01/2014–31/01/2017) and after (01/02/2017–30/06/2020), within the North site then the South site
  2. ASA American Society of Anesthesiologists, BMI Body mass index, CCFM Cutaneous commensal flora microorganisms, OS Osteosynthesis, SSI Surgical site infection, UEF Upper end of the femur